QGEN
Price
$49.94
Change
-$0.31 (-0.62%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
9.52B
Earnings call today
TMO
Price
$466.50
Change
-$0.07 (-0.02%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
220.19B
78 days until earnings call
Interact to see
Advertisement

QGEN vs TMO

Header iconQGEN vs TMO Comparison
Open Charts QGEN vs TMOBanner chart's image
Qiagen
Price$49.94
Change-$0.31 (-0.62%)
Volume$24.45K
Capitalization9.52B
Thermo Fisher Scientific
Price$466.50
Change-$0.07 (-0.02%)
Volume$3.45K
Capitalization220.19B
QGEN vs TMO Comparison Chart in %
Loading...
QGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QGEN vs. TMO commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QGEN is a Hold and TMO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (QGEN: $50.25 vs. TMO: $466.57)
Brand notoriety: QGEN and TMO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: QGEN: 107% vs. TMO: 71%
Market capitalization -- QGEN: $9.52B vs. TMO: $220.19B
QGEN [@Medical Specialties] is valued at $9.52B. TMO’s [@Medical Specialties] market capitalization is $220.19B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QGEN’s FA Score shows that 0 FA rating(s) are green whileTMO’s FA Score has 0 green FA rating(s).

  • QGEN’s FA Score: 0 green, 5 red.
  • TMO’s FA Score: 0 green, 5 red.
According to our system of comparison, QGEN is a better buy in the long-term than TMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QGEN’s TA Score shows that 3 TA indicator(s) are bullish while TMO’s TA Score has 6 bullish TA indicator(s).

  • QGEN’s TA Score: 3 bullish, 5 bearish.
  • TMO’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TMO is a better buy in the short-term than QGEN.

Price Growth

QGEN (@Medical Specialties) experienced а -1.43% price change this week, while TMO (@Medical Specialties) price change was -3.79% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.73%. For the same industry, the average monthly price growth was -1.40%, and the average quarterly price growth was -4.07%.

Reported Earning Dates

QGEN is expected to report earnings on Nov 04, 2025.

TMO is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Medical Specialties (-1.73% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($220B) has a higher market cap than QGEN($9.52B). TMO has higher P/E ratio than QGEN: TMO (37.38) vs QGEN (27.85). QGEN YTD gains are higher at: 16.707 vs. TMO (-10.146). TMO has higher annual earnings (EBITDA): 11.1B vs. QGEN (689M). TMO has more cash in the bank: 8.08B vs. QGEN (1.06B). QGEN has less debt than TMO: QGEN (1.53B) vs TMO (34.9B). TMO has higher revenues than QGEN: TMO (42.9B) vs QGEN (1.97B).
QGENTMOQGEN / TMO
Capitalization9.52B220B4%
EBITDA689M11.1B6%
Gain YTD16.707-10.146-165%
P/E Ratio27.8537.3875%
Revenue1.97B42.9B5%
Total Cash1.06B8.08B13%
Total Debt1.53B34.9B4%
FUNDAMENTALS RATINGS
QGEN vs TMO: Fundamental Ratings
QGEN
TMO
OUTLOOK RATING
1..100
8273
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
6574
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4757
P/E GROWTH RATING
1..100
6984
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QGEN's Valuation (50) in the Medical Specialties industry is in the same range as TMO (50). This means that QGEN’s stock grew similarly to TMO’s over the last 12 months.

QGEN's Profit vs Risk Rating (65) in the Medical Specialties industry is in the same range as TMO (74). This means that QGEN’s stock grew similarly to TMO’s over the last 12 months.

QGEN's SMR Rating (100) in the Medical Specialties industry is in the same range as TMO (100). This means that QGEN’s stock grew similarly to TMO’s over the last 12 months.

QGEN's Price Growth Rating (47) in the Medical Specialties industry is in the same range as TMO (57). This means that QGEN’s stock grew similarly to TMO’s over the last 12 months.

QGEN's P/E Growth Rating (69) in the Medical Specialties industry is in the same range as TMO (84). This means that QGEN’s stock grew similarly to TMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QGENTMO
RSI
ODDS (%)
Bearish Trend 2 days ago
37%
Bearish Trend 2 days ago
49%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
50%
Momentum
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 9 days ago
61%
Declines
ODDS (%)
Bearish Trend about 1 month ago
51%
Bearish Trend 5 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
64%
Aroon
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
QGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MHNC17.490.39
+2.29%
MAIDEN HOLDINGS NORTH AMERICA Ltd
FTEC205.124.46
+2.22%
Fidelity MSCI Information Tech ETF
FCO6.600.10
+1.54%
abrdn Global Income Fund
MFUS53.430.63
+1.18%
PIMCO RAFI Dyn Multi-Factor US Eq ETF
IAK127.651.28
+1.01%
iShares US Insurance ETF

QGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QGEN has been closely correlated with DHR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if QGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QGEN
1D Price
Change %
QGEN100%
+0.62%
DHR - QGEN
67%
Closely correlated
+0.19%
A - QGEN
63%
Loosely correlated
+1.18%
RVTY - QGEN
61%
Loosely correlated
+0.10%
BRKR - QGEN
60%
Loosely correlated
-8.62%
TMO - QGEN
60%
Loosely correlated
+0.76%
More

TMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMO has been closely correlated with A. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMO
1D Price
Change %
TMO100%
+0.76%
A - TMO
79%
Closely correlated
+1.18%
DHR - TMO
79%
Closely correlated
+0.19%
WAT - TMO
76%
Closely correlated
-1.63%
RVTY - TMO
73%
Closely correlated
+0.10%
BRKR - TMO
70%
Closely correlated
-8.62%
More